A carregar...

The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the Cyclin-CDK-Rb pathway

Loss of normal growth control is a hallmark of cancer progression. Therefore, understanding the early mechanisms of normal growth regulation and the changes that occur during preneoplasia may provide insights of both diagnostic and therapeutic importance. Models of dysplasia that help elucidate the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cabrera, M. Carla, Díaz-Cruz, Edgar S., Kallakury, Bhaskar V. S., Pishvaian, Michael J., Grubbs, Clinton J., Muccio, Donald D., Furth, Priscilla A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368087/
https://ncbi.nlm.nih.gov/pubmed/22508966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0532-T
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!